Extravasation of 99mTc-labeled radiopharmaceuticals is generally considered to require no specific intervention. In the presented case, the use of hyaluronidase could have minimized the adverse effects resulting from such an extravasation. Currently, no guidelines exist regarding the use of hyaluronidase after extravasation of [99mTc]Tc-HDP. Considering the low risk of administering hyaluronidase, it should be considered to limit the risk of injury after extravasation of [99mTc]Tc-HDP.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11272945 | PMC |
| http://dx.doi.org/10.1002/prp2.1232 | DOI Listing |
Publication Analysis
Top Keywords
hyaluronidase extravasation
8
extravasation [99mtc]tc-hdp
8
extravasation
5
treatment [99mtc]tc-hydroxy-diphosphonate
4
[99mtc]tc-hydroxy-diphosphonate [99mtc]tc-hdp
4
[99mtc]tc-hdp extravasation
4
hyaluronidase
4
extravasation hyaluronidase
4
extravasation 99mtc-labeled
4
99mtc-labeled radiopharmaceuticals
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!